Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genome Research Limited (GRL) is the charitable company that operates the Wellcome Sanger Institute, one of the world's leading centers for genomic research. Based at the Wellcome Genome Campus, GRL focuses on understanding the role of genetics in health and disease through large-scale sequencing and analysis. While primarily a research organization, GRL actively translates its findings into clinical applications through spin-out companies and extensive industry partnerships. Its work spans human genetics, cancer, infectious diseases, and the development of advanced genomic technologies like CRISPR and single-cell sequencing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genome Research.